4-Hexylresorcinol - CAS 136-77-6
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
4-Hexylresorcinol
Catalog Number:
136-77-6
Synonyms:
1-(2',4'-Dihydroxyphenyl)hexane;1-(2,4-Dihydroxyphenyl)hexane;1,3-Benzenediol, 4-hexyl-;1,3-Benzenediol,4-Hexyl-1,3-benzenediol;1,3-Dihydroxy-4-Hexylbenzene;1,3-Dihydroxy-4-n-hexylbenzene
CAS Number:
136-77-6
Description:
4-Hexylresorcinol, a phenol derivative, could be commonly used as antioxidant, vermifuge and food additives.
Molecular Weight:
194.27
Molecular Formula:
C12H18O2
Quantity:
Grams-Kilos
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CCCCCCC1=C(C=C(C=C1)O)O
InChI:
InChI=1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3
InChIKey:
WFJIVOKAWHGMBH-UHFFFAOYSA-N
Targets:
Others
Chemical Structure
CAS 136-77-6 4-Hexylresorcinol

Related Products


CAS 501-68-8 Beclamide

Beclamide
(CAS: 501-68-8)

Beclamide is a chlorinated benzylpropanamide that possesses anticonvulsant activity, has been used for the treatment of tonic-clonic seizyres and has sedative p...

CAS 342785-41-5 FR-202306

FR-202306
(CAS: 342785-41-5)

FR-202306 is a synthetic peptide deformylase (PDF) inhibitor.

LY 135305
(CAS: 123199-75-7)

LY 135305 is a bio-active molecular under the development of Eli Lilly. It can inhibit spontaneous lung metastasis in a dose-dependent manner.

CAS 130-40-5 Riboflavin phosphate sodium

Riboflavin phosphate sodium
(CAS: 130-40-5)

Riboflavin phosphate sodium, a Riboflavin derivative, is a commonly existed nutritional factor and could improve the biomechanical stiffness of corneal.

CAS 1415-73-2 Aloin

Aloin
(CAS: 1415-73-2)

Aloin, a natural anthracycline from Aloe vera, is a tyrosinase inhibitor.

Aftobetin Hydrochloride
(CAS: 1353222-83-9)

CAS 461-89-2 6-Azauracil

6-Azauracil
(CAS: 461-89-2)

6-Azauracil inhibits enzymes in nucleoside synthesis and depletes the intracellular GTP/UTP pool. It is being used to identify mutations in transcriptional elon...

CAS 470-37-1 Cinobufagin

Cinobufagin
(CAS: 470-37-1)

Cinobufagin can inhibit the proliferation of U-2OS cells, and induce cell apoptosis. The potential mechanism of Cinobufagin-induced apoptosis may be related to ...

CAS 10338-51-9 Salidroside

Salidroside
(CAS: 10338-51-9)

Salidroside, a phenylpropanoid glycoside isolated from Rhodiola rosea, has been reported to have a broad spectrum of pharmacological properties.

CAS 54048-10-1 Etonogestrel

Etonogestrel
(CAS: 54048-10-1)

A impurity of Desogestrel, which is a progestogen.

CAS 122008-78-0 Cyhalofop

Cyhalofop
(CAS: 122008-78-0)

Cyhalofop(Cyhalofop acid) is a recently registered herbicide from the aryloxyphenoxy propionate group in India to control a wide range of grass weed species at ...

CAS 80321-63-7 Gynostemma Extract

Gynostemma Extract
(CAS: 80321-63-7)

Gynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum.

CAS 938448-87-4 Bucladesine calcium salt

Bucladesine calcium salt
(CAS: 938448-87-4)

Bucladesine calcium salt is a membrane permeable selective activator of PKA. It is absorbed very rapidly and almost completely when the aqueous solution is appl...

CAS 1083-57-4 Bucetin

Bucetin
(CAS: 1083-57-4)

Bucetin, a phenacetin analog, has antipyretic and analgesic effect. It has been discontinued for showing renal toxicity.

CAS 355129-15-6 Eprotirome

Eprotirome
(CAS: 355129-15-6)

Eprotirome is a synthetic thyroid hormone mimetic as a thyroid hormone receptor beta agonists, lowers total and low-density lipoprotein cholesterol up to 40% wi...

CP-432
(CAS: 431990-08-8)

CP-432 is an EP4 prostaglandin agonist , potential useful for the treatment of glaucoma and ocular hypertension.

CAS 176957-55-4 CCT007093

CCT007093
(CAS: 176957-55-4)

CCT007093 is a potent PPM1D inhibitor or WIP1 inhibitor that selectively reduces viability of human tumour cell lines

CAS 71939-50-9 Dihydroartemisinin (DHA)

Dihydroartemisinin (DHA)
(CAS: 71939-50-9)

Dihydroartemisinin (DHA) is a semi-synthetic derivative of artemisinin and isolated from the traditional Chinese herb Artemisia annua.

CAS 961-07-9 2(acute)-Deoxyguanosine

2(acute)-Deoxyguanosine
(CAS: 961-07-9)

2(acute)-Deoxyguanosine is composed of the purine nucleoside guanine linked by its N9 nitrogen to the C1 carbon of deoxyribose. It is a purine nucleoside that u...

CAS 116-52-9 DCU

DCU
(CAS: 116-52-9)

Dicloralurea, a veterinary food additive, could restrain the formation of methane in herbicide ruminants for behaving as a growth stimulant.

Reference Reading


1.Development and validation of an analytical method for the determination of 4-hexylresorcinol in food.
Kim YH1, Kim JM1, Lee JS1, Gang SR2, Lim HS3, Kim M3, Lee OH4. Food Chem. 2016 Jan 1;190:1086-92. doi: 10.1016/j.foodchem.2015.06.051. Epub 2015 Jun 19.
This study presents a method validation for extraction and quantitative analysis of 4-hexylresorcinol residues in shrimp and crab meat using HPLC-FLD. We were focused on the collaboratively analysis of each shrimp and crab meat samples, and developed LC-MS/MS method for the correct confirmation of the identity of compound. Validation parameters; selectivity, linearity, LOD, LOQ, accuracy, precision, and measurement of uncertainty were attained. The measurement of uncertainty was based on the precision study, data related to the performance of the analytical process and quantification of 4-hexylresorcinol. For HPLC-FLD analysis, the recoveries of 4-hexylresorcinol from spiked samples at levels of 0.2-10.0 ppm ranged from 92.54% to 97.67% with RSDs between 0.07% and 1.88%. According to these results, the method has been proven to be appropriate for extraction and determination of 4-hexylresorcinol, and can be used to maintain the safety of shrimp and crab products containing 4-hexylresorcinol residues.
2.Tyrosinase-Catalyzed Hydroxylation of 4-Hexylresorcinol, an Antibrowning and Depigmenting Agent: A Kinetic Study.
Ortiz-Ruiz CV1, Berna J1, Rodriguez-Lopez JN1, Tomas V1, Garcia-Canovas F1. J Agric Food Chem. 2015 Aug 12;63(31):7032-40. doi: 10.1021/acs.jafc.5b02523. Epub 2015 Jul 29.
4-Hexylresorcinol (HR) is a compound used in the food and cosmetic industries as an antibrowning and lightening agent. Its use is mainly attributed to its inhibitory effect on the enzyme tyrosinase. However, the enzyme hydroxylates HR to an o-diphenol, which it then oxidizes to an o-quinone, which rapidly isomerizes to p-quinone. For tyrosinase to act in this way, the Eox form (oxy-tyrosinase) must be present in the reaction medium, which can be brought about by (a) hydrogen peroxide, (b) ascorbic acid, or (c) catalytic concentrations of o-diphenol and a reductant (NADH) to maintain it constant. This work demonstrates that HR is a substrate of tyrosinase and proposes a mechanism for its action. Its kinetic characterization provides a catalytic constant of 0.85 ± 0.04 s(-1) and a Michaelis constant of 60.31 ± 6.73 μM.
3.Silk fibroin and 4-hexylresorcinol incorporation membrane for guided bone regeneration.
Lee SW1, Kim SG, Song JY, Kweon H, Jo YY, Lee KG, Kang SW, Yang BE. J Craniofac Surg. 2013 Nov;24(6):1927-30. doi: 10.1097/SCS.0b013e3182a3050c.
The objective of this study was to demonstrate that a silk fibroin (SF) and 4-hexylresorcinol (4-HR) incorporation membrane could be used for a guided bone regeneration technique. Fourier transform infrared measurements were obtained to determine change of physical property of SF membrane by 4-HR incorporation. Two peri-implant defects, 3.0 × 5.0 mm (width × length), were prepared on the lateral side of the implant hole in the tibia of New Zealand white rabbits (n = 8). The peri-implant defect was left unfilled in the control group. Silk fibroin + 4-HR membrane was applied to the peri-implant defect in the experimental group. The 8 animals were killed at 8 weeks after implantation. Subsequently, removal torque test and histomorphometric evaluation were done. Fourier transform infrared spectroscopy showed no specific chemical interaction between 4-HR and SF. In the histomorphometric analysis, the mean bone regeneration was 18.3 ± 1.9 mm(2) in the experimental group and 9.
4.Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).
Wentworth AB1, Yiannias JA2, Keeling JH3, Hall MR3, Camilleri MJ4, Drage LA5, Torgerson RR5, Fett DD6, Prakash AV7, Scalf LA8, Allen EM5, Johnson JS2, Singh N2, Nordberg Linehan DL3, Killian JM9, Davis MD10. J Am Acad Dermatol. 2014 Feb;70(2):269-75.e4. doi: 10.1016/j.jaad.2013.09.047. Epub 2013 Nov 20.
BACKGROUND: Patch testing is essential for identification of culprits causing allergic contact dermatitis.